VIRO logo

ViroGates A/S Stock Price

CPSE:VIRO Community·DKK 100.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VIRO Share Price Performance

DKK 10.80
1.62 (17.65%)
DKK 10.80
1.62 (17.65%)
Price DKK 10.80

VIRO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

ViroGates A/S Key Details

DKK 9.0m

Revenue

DKK 1.9m

Cost of Revenue

DKK 7.1m

Gross Profit

DKK 17.3m

Other Expenses

-DKK 10.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 20, 2026
-1.10
78.46%
-113.54%
25.1%
View Full Analysis

About VIRO

Founded
2000
Employees
7
CEO
Jakob Knudsen
WebsiteView website
www.virogates.com

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

Recent VIRO News & Updates

Recent updates

No updates